Injection site reactions (redness, swelling, mild irritation) are common and typically resolve within 24-48 hours
Research-use-only catalogue Continue to the product record
BPC-157 is sold for laboratory research use only
TB-500, on the other hand, enters the bloodstream and spreads everywhere injection site doesn't matter for that component
Comparative studies looking at dose-response on either compound separately should use the standalone preparations to control concentration independently
We will also continue to advocate for a system that better aligns with the science." In a clinical study, tirzepatide 5 mg, along with a reduced calorie diet and increased physical activity, achieved an average of 15% weight loss over 72 weeks compared to 3.1% for placebo